Congratulations to our Scientific Advisor Dr. Matthew Marx, co-inventor of the clinical KRAS G12C inhibitor adagrasib, which was recently voted #2 drug of the year.

It was a great way to celebrate International Women's Day as Dr. Teri Suzuki presented at the Eureka Institute Conference.

Proud to be one of 12 out of 98 companies given the opportunity to share how we are fighting cancer safely.

Reglagene's Director of Operations Michael Abrahamson presents at Destination Startup.

We’re honored to be recognized as an up-and-comer in the life science arena.

Look forward to attending Destination Startup in Denver, Colorado next month.

Tune in to today's Sipping on SBIR Success!

We moved!

Welcome to the team, Dr. Helen Yeoman!